The largest database of trusted experimental protocols

13 protocols using c8 column

1

Protein Purification and Mass Spectrometry Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Excess TCEP was removed by exchanging the protein buffer to buffer R without TCEP using a PD-10 column (GE Healthcare). The concentration of the protein was determined using a Nanodrop spectrometer based on absorption at 280 nm. The DCA linker (300 μM) was added to 2 μM fusion protein in buffer R with 20 % (v/v) acetonitrile and incubated at 30 °C for 2 hours or 42 °C for 1 hour before being analyzed using a Waters ACQUITY UPLC equipped with a C8 column and SQ Detector 2. The acquired mass of the protein was deconvoluted using MassLynx software.
+ Open protocol
+ Expand
2

Solid-Phase Synthesis of Stearic Acid-Conjugated Peptides

Check if the same lab product or an alternative is used in the 5 most similar protocols
All peptides were synthesized using a Liberty automated microwave peptide synthesizer (CEM Co., Matthews, NC) together with a standard solid-phase Fmoc chemistry protocol. Rink amide resin with a loading capacity of 0.44 mmol/g was used as a solid phase to obtain C-terminally amidated peptides. Coupling of the amino acids was achieved using HBTU in DMF as an activator and DIEA in NMP as an active base. A 20% (v/v) solution of piperidine in DMF was added to the resin for deprotection. After every coupling or deprotection, the resin was washed with DMF and DCM for three times respect. Amino acids were individually coupled to Rink amide resin, followed by the amino group in the side chain of lysine conjugation of stearic acid. Final cleavage was performed with 10 mL of TFA (90%)/thioanisole (5%)/ethanedithiol (3%)/anisole (2%) for 3 h at room temperature. The products were purified by preparative reverse-phase high-performance liquid chromatography (RP-HPLC) using a C8 column (Waters, USA). All peptides were purified to >95% purity. The molecular weights (MWs) of the peptides were determined by Electrospray Ionization Quadrupole-Time of Flight mass spectrometry (MALDI-TOF-MS; Waters Micromass Q-TOF Micro Mass Spectrometer).
+ Open protocol
+ Expand
3

UPLC-MS Lipidomics Analysis Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
The dried lipid samples from the organic upper phase were re-suspended in 400 μL of LC-grade isopropanol: acetonitrile (3:7 [v:v]) mixture. Two μL from each sample were injected and separated on an Acquity UPLC system (Waters, Machester, UK). Chromatographic separations were performed on a C8 column (100 mm × 2.1 mm containing 1.7 μm diameter particles, Waters, Machester, UK) at a column oven temperature of 40 °C. The flow rate was set to 400 μL/min and the auto-sampler was maintained at 10 °C. The mobile phases consisted of 1% 1 M ammonium acetate, 0.1% acetic acid in UPLC MS grade water (solvent A) and 1% 1 M ammonium acetate, 0.1% acetic acid in acetonitrile/isopropanol 7:3 (v:v) (solvent B). The steps of the gradient profile were 45% A from 0 to 1 min, 45% A to 35% A from 1 to 4 min, 35% A to 11% A from 4 to 12 min, 11% A to 1% A from 12 to 15 min, 1% A from 15 to 18 and 45% A from 18 to 22 min. The mass spectra were acquired using high resolution mass spectrometer (Orbitrap XL, Thermo Scientific, Bremen, Germany) in both positive and negative ionization mode covering the mass range between 150 and 1500 m/z. The MS data were collected in the full scan mode [21 ,22 ].
+ Open protocol
+ Expand
4

Protein Purification and Mass Spectrometry Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Excess TCEP was removed by exchanging the protein buffer to buffer R without TCEP using a PD-10 column (GE Healthcare). The concentration of the protein was determined using a Nanodrop spectrometer based on absorption at 280 nm. The DCA linker (300 μM) was added to 2 μM fusion protein in buffer R with 20 % (v/v) acetonitrile and incubated at 30 °C for 2 hours or 42 °C for 1 hour before being analyzed using a Waters ACQUITY UPLC equipped with a C8 column and SQ Detector 2. The acquired mass of the protein was deconvoluted using MassLynx software.
+ Open protocol
+ Expand
5

Peptide Separation and Bioactivity Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Peptides were separated by reversed-phase chromatography on a HPLC (Waters, USA) system equipped with a C8 column (250 mm × 4.6 mm × 5 mm; Waters) and photodiode array detector (Spectra System Thermo Scientific, USA) A gradient elution was applied from 100 to 0% A in 56 min at flow rate of 1 mL/min. A binary mobile phase consisted of solvent A: 0.065% trifluoroacetic acid [TFA] in water/acetonitrile [ACN] 98:2, and solvent B: 0.065% TFA in water/ACN 35:65. Detection was performed at 280 nm and temperature was set at 40 °C. The injection volume was 200 µL. Fractions were manually collected every 1 min in Eppendorf tubes and protein content was evaluated by the Bradford assay. Finally, samples were lyophilized (Labconco DrySystem/freezone 4.5) and bioactivity analysis was carried out only on the lyophilized samples containing protein.
+ Open protocol
+ Expand
6

Pigment and Protoporphyrin IX Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
For the pigment analysis, the leaves were collected from the sprl1 mutant and its wild type at the seedling stage and the heading stage, respectively. The pigments were extracted from 0.2 g of fresh leaves with 80% acetone in the dark at 4 °C for 48 h. The contents of chlorophyll (Chl) and carotenoids (Caro) were measured at wavelengths of 470 nm, 646 nm, and 663 nm using the BIOMATE 3S UV-Visible Spectrophotometer (Thermo scientific, Waltham, MA, USA) and were calculated according to the method of Lichtenthaler and Wellburn [52 (link)]:


For the Proto IX analysis, 0.1 g fresh leaves at the seedling stage were homogenized in 1 mL methanol/acetone/0.1 M NaOH (9:10:1, v/v/v), and the homogenates were centrifuged at 7197 g (Eppendorf 5430R; 7830 rpm) at 1 °C for 20 min. To oxidize the Protogen IX into Proto IX, 5 μL of 1 M acetic acid and 5μL of 2-butanone peroxide was added to 200 μL supernatant [28 (link)]. Then, the Proto IX was analyzed by HPLC on a C8 column (4.6 × 150 mm, 3.5μm; Waters) according to the method of Wang [53 (link)]. The elution profiles were detected by fluorescence, with excitation at 405 nm and emission at 625 nm [28 (link)]. The Proto IX was quantified by using the Proto IX standard (Frontier Scientific, Logan, UT, United States).
+ Open protocol
+ Expand
7

Quantitative Lipid Analysis by HPLC-MS

Check if the same lab product or an alternative is used in the 5 most similar protocols
Extracted lipids were resuspended in organic buffer (methanol containing 1 mM ammonium formate and 0.2% formic acid). A two-buffer mobile system, aqueous and organic was used. Aqueous buffer contained 2 mM ammonium formate and 0.2% formic acid. From each sample, 5 µl was injected by the Autosampler, and mobile buffer was pumped at a flow rate of 0.3 ml min−1 to the HPLC fitted with the C8 column (Waters, MA, USA). SL species were detected by multiple reaction monitoring (MRM) methods using QTRAP® 4500 (SCIEX, USA) mass spectrometer. The MRM scans used were described earlier by Kumar et al. (2021 (link)).
+ Open protocol
+ Expand
8

Protein Purification Analysis by RP-HPLC

Check if the same lab product or an alternative is used in the 5 most similar protocols
RP-HPLC was used to analyze the protein in the top phase before and after purification. The conditions for RP-HPLC were as follows: Waters C8 column (4.6 mm × 150 mm), 0.05% TFA in acetonitrile as mobile phase A, 0.05% aqueous TFA as mobile phase B, flow rate of 1.00 mL/min, and detection wavelength of 280 nm. Gradient elution was programmed as follows: the concentration of mobile phase A was increased from 7% to 70% in 17 min and decreased to 7% before 22 min [27 (link)].
+ Open protocol
+ Expand
9

Plasma Acylcarnitine Profiling by LC-MS

Check if the same lab product or an alternative is used in the 5 most similar protocols
The 20 μL plasma sample was extracted with 180 μL methanol containing internal standards in a 96-well plate with a filter membrane. After centrifugation, 50 μL of the filtrate was transferred to a microtiter plate and diluted 4 times for analysis [24 (link)]. The chromatographic separation was achieved on a C8 column (2.1 × 100 mm i.d., 1.7 μm, Waters Corp., Milford, MA, USA) at 45 °C with mobile phase A (0.1% formic acid in water, v/v) and mobile phase B (acetonitrile), and the flow rate was set at 0.5 mL/min. The gradient profile was as follows: linear gradient 0–2.5% B, 0.5 min, 2.5–12% B, 2 min, 12–36% B, 0.5 min, and keep 36% B, 1 min, 36–100% B, 0.2 min, and keep 100% B, 1.3 min. The column was then re-equilibrated for 1.4 min. The parameters of MS were as follows: capillary voltage 1 kV; desolvation gas flow 1000 L/h; desolvation temperature 550 °C; source temperature 150 °C. Acylcarnitines were quantified in positive electrospray ionization mode.
+ Open protocol
+ Expand
10

Quantitative Analysis of CFTR Modulators

Check if the same lab product or an alternative is used in the 5 most similar protocols
IVA and LUMA were purchased from SelleckChem, USA. IVA-carboxylate (Catalogue number 510242247CS) and hydroxymethyl-IVA (Catalogue number 510240849CS) were from Clearsynth (Canada) and were used as internal standards (IS) in methanol at 10 μg/mL. Methanol (MeOH, LC-MS grade), acetonitrile (ACN, LC-MS grade) and formic acid were purchased from Sigma-Aldrich (Australia). Experiments were performed on a triple-quadrupole Shimadzu 8030 LC-MS and a Nexera X2 Shimadzu HPLC (SPD-M30A detector) systems using a Waters C8 column (5 μm, 3.9×50 mm i.d.). Plasma was obtained from the Australian Red Cross. Plasma and sputum samples were collected from two compliant volunteers receiving ORKAMBI or KALYDECO therapy.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!